Weight | 510.631 g/mol |
---|---|
Formula | C29H38N2O6 |
Hydrogen Acceptors | 6 |
Hydrogen Donors | 1 |
Aromatic Rings | 2 |
Rotatable Bonds | 12 |
Atrasentan (173937-91-2)
"What do you need help with?"
LabBot
- Sigma-Aldrich - Search for Atrasentan
- Fisher Scientific - Search for Atrasentan
- TCI - Search for Atrasentan
- Effect of Endothelin-A Receptor Blockade With Atrasentan on Tumor Progression in Men With Hormone-Refractory Prostate Cancer: A Randomized, Phase II, Placebo-Controlled Trial (Journal of Clinical Oncology, 2003)
- A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer (Cancer, 2007)
- Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer. (Cancer, 2008)
- Atrasentan, an Endothelin-Receptor Antagonist for Refractory Adenocarcinomas: Safety and Pharmacokinetics (Journal of Clinical Oncology, 2002)
- Addition of Atrasentan to Renin-Angiotensin System Blockade Reduces Albuminuria in Diabetic Nephropathy (Journal of The American Society of Nephrology, 2011)
- Suppression of prostate cancer induced bone remodeling by the endothelin receptor a antagonist atrasentan (The Journal of Urology, 2003)
-
Including Acute Oral Tox, Skin Sensitization, Eye Irritation, Aquatic Tox, & more. -
SMILESCCCCN(CCCC)C(=O)CN1CC(C(C1C2=CC=C(C=C2)OC)C(=O)O)C3=CC4=C(C=C3)OCO4
-
InChIKeyMOTJMGVDPWRKOC-UHFFFAOYSA-N
- Pubchem - Atrasentan
- Wikipedia - atrasentan
Atrasentan is an experimental drug that is being studied for the treatment of various types of cancer, including non-small cell lung cancer. It is also being investigated as a therapy for diabetic kidney disease. Atrasentan failed a phase 3 trial for prostate cancer in patients unresponsive to hormone therapy.
Suppliers
Most-cited Publications
Safety
Alternate Names
External Links
Similar Compounds
HALOPERIDOL DECANOATE
(74050-97-8)
1 alternate name
3 suppliers
spiperone
(749-02-0)
1 alternate name
3 suppliers
LOFEPRAMINE
(23047-25-8)
1 alternate name
3 suppliers
FENOLDOPAM MESYLATE
(67227-57-0)
1 alternate name
3 suppliers
Flurazepam monohydrochloride
(36105-20-1, 1172-18-5)
1 alternate name
3 suppliers
27955-94-8
(27955-94-8)
1 alternate name
3 safety hazards
3 suppliers
LORCAINIDE
(59729-31-6)
1 alternate name
3 suppliers
TRI-P-CRESYL PHOSPHATE
(78-32-0, 1330-78-5)
1 alternate name
3 safety hazards
3 suppliers
Paroxetine hydrochloride
(78246-49-8, 110429-35-1)
1 alternate name
3 suppliers
LOBELINE HYDROCHLORIDE
(134-63-4)
1 alternate name
3 suppliers
Fenpropathrin
(39515-41-8)
1 alternate name
5 safety hazards
3 suppliers
Halofenozide
(112226-61-6)
1 alternate name
1 safety hazard
3 suppliers
BIS(2-ETHYLHEXYL) TEREPHTHALATE
(6422-86-2)
1 alternate name
3 suppliers
Tris(4-isopropylphenyl) phosphate
(2502-15-0, 68937-41-7, 26967-76-0)
1 alternate name
3 suppliers
4'-Chlorodiazepam
(14439-61-3)
1 alternate name
3 suppliers
Flurazepam dihydrochloride
(1172-18-5)
1 alternate name
3 suppliers
Tris(3,4-dimethylphenyl) phosphate
(3862-11-1)
1 alternate name
3 suppliers
Octocrylene
(6197-30-4)
1 alternate name
3 suppliers
pridinol
(511-45-5)
1 alternate name
3 suppliers
Pararosaniline base
(467-62-9)
1 alternate name
3 suppliers
rebamipide
(90098-04-7)
1 alternate name
3 suppliers
Enterolactone
(76543-15-2)
1 alternate name
3 suppliers
BISPHENOL A DIGLYCIDYL ETHER
(1675-54-3, 500008-19-5)
1 alternate name
4 safety hazards
3 suppliers
Fenpyroximate
(111812-58-9)
1 alternate name
3 suppliers
Annatto
(626-76-6, 1393-63-1)
1 alternate name
3 suppliers
SARAFLOXACIN HYDROCHLORIDE
(91296-87-6)
1 alternate name
3 suppliers
FLURIDONE
(59756-60-4)
1 alternate name
3 suppliers
Octabenzone
(1843-05-6)
1 alternate name
3 suppliers
Trixylenyl phosphate
(25155-23-1, 3862-12-2)
1 alternate name
3 suppliers
Basic Red 9
(569-61-9, 25620-78-4)
1 alternate name
2 safety hazards
3 suppliers
Pararosaniline
(479-73-2)
1 alternate name
3 suppliers
DIETHYLCARBAMAZINE CITRATE
(1642-54-2)
1 alternate name
3 suppliers
Solvent green 3
(128-80-3)
1 alternate name
3 suppliers
Tiamulin
(55297-95-5)
1 alternate name
3 suppliers
Tiamulin
(55297-95-5)
1 alternate name
3 suppliers
Tiamulin
(55297-95-5)
1 alternate name
3 suppliers
Thiamutilin
(55297-95-5)
1 alternate name
3 suppliers
Tiamulin
(55297-95-5)
1 alternate name
3 suppliers
Tiamulin
(55297-95-5)
1 alternate name
3 suppliers
Tiamulin
(55297-95-5)
1 alternate name
3 suppliers
RALOXIFENE HYDROCHLORIDE
(82640-04-8)
1 alternate name
3 suppliers
FENARIMOL
(60168-88-9)
1 alternate name
4 safety hazards
3 suppliers
TIROFIBAN HYDROCHLORIDE
(142373-60-2)
1 alternate name
3 suppliers
Tricaprin
(621-71-6)
1 alternate name
3 suppliers
Darifenacin hydrobromide
(133099-07-7)
1 alternate name
3 suppliers
Talinolol
(57460-41-0)
1 alternate name
3 suppliers
Bitertanol
(55179-31-2)
1 alternate name
2 safety hazards
3 suppliers
Diphenhydramine citrate
(88637-37-0)
1 alternate name
3 suppliers
CAS Directory